Texas Instruments’ (NASDAQ: TXN) reported a 2% drop in EPS and 7% decline in revenue for the first quarter of 2020. However, the results exceeded analysts’ expectations. TXN stock rose about 3% immediately after the earnings announcement in the after-market session.
To reflect the increased uncertainty, the company expanded the range of the second-quarter 2020 outlook. EPS is expected to be in the range of $0.64 and $1.04 and revenue is projected to be in the range of $2.61 billion to $3.19 billion for the second quarter.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment